Eur/usd: euro remains in question ahead of eu gdp

I remind that lately the European common currency has discounted several positive data for it, such as the significant de-esc...

January 31, 2023, 9:29 am

Us is moving towards sending abrams tanks to ukraine - report

An unnamed official cited by Reuters said the US is moving towards sending Abrams tanks to Ukraine.

You have to wonder when the esc...

January 24, 2023, 3:11 pm

Mannkind’s inhaled clofazimine will advance to an adaptive phase 2/3 study for potential treatment of rare lung disease

Direct delivery of clofazimine to the lungs may provide a treatment option for nontuberculous mycobacterial (NTM) lung disease that potentially overco...

January 23, 2023, 11:05 am

Viracta therapeutics announces first clinical response in epstein-barr virus-positive (ebv+) solid tumor setting and outlines key 2023 clinical objectives

Partial response (PR) observed in third dose level of the Phase 1b dose escalation study of Nana-val in...

January 8, 2023, 6:00 pm

Hyderabad: gold price sees sudden spike, bullion traders worried

Market experts say that surge is majorly due to the US Fed meeting minutes outcome that will come out this week, weakening Indian rupee and the fears ...

January 4, 2023, 4:14 am

European stocks tumble, end final session of year on weak note

European stocks ended the final session of Year 2022 on a very weak note as fears about a recession, worries about rising rates, surging Covid cases i...

December 30, 2022, 5:27 pm

Eur/usd struggles to defend 1.0600 as market fears renew us dollar demand

EUR/USD holds lower grounds after closely avoiding the 1.0600 breakdown. Distrust on China unlock, global restrictions on travelers from Beijing rever...

December 28, 2022, 11:44 pm

Genprex gets green light for continuation of dose escalation phase 1 of acclaim-1 phase 1/2 clinical trial of reqorsa

Genprex, Inc. (NASDAQ:GNPX) has announced that the Safety Review Committee (SRC) has approved continuation to the third and final cohort in the dose e...

December 14, 2022, 8:27 am

Fate therapeutics highlights ipsc-derived, off-the-shelf car nk cell programs for multiple myeloma at 2022 ash annual meeting

Interim Phase 1 Data of FT576 BCMA-targeted Product Candidate Show Clinical Activity in Initial Single-dose Esc...

December 10, 2022, 7:46 pm

Fate therapeutics announces clinical safety and activity data of first-ever ipsc-derived car t-cell therapy at 2022 ash annual meeting

FT819 Off-the-Shelf CAR T-cell Product Candidate Derived from Clonal Engineered Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into TRAC...

December 10, 2022, 3:00 pm

Olema oncology announces op-1250 demonstrates attractive combinability with cdk 4/6 inhibitor palbociclib in phase 1b dose escalation study

OP-1250 in combination with palbociclib was well-tolerated in patients with ER+/HER2- breast cancer, with no dose-limiting toxicities, and no observed...

December 7, 2022, 8:37 pm

Tilt holdings announces december conference schedule

PHOENIX, Dec. 01, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT ) (OTCQX: TLLTF ), a global provider of can...

December 1, 2022, 7:30 am

Viracta therapeutics announces preliminary dose-ranging data from the phase 1b/2 trial of nana-val in advanced epstein-barr virus-positive (ebv+) solid tumors at the esmo immuno-oncology congress

Data from first two dose levels of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma support continued dose esc...

November 30, 2022, 11:10 pm

Rli: steady growth and capital gains point to lasting value

For much of the past year, the stock market theme has been deep undervalation brought on by the market-...

November 30, 2022, 10:52 am

Markets cautious, awaiting eurozone cpi and development in china

Overall, the forex markets are very cautious for now, awaiting the key events of the week, including Eurozone CPI flash today and US non-farm payrolls...

November 30, 2022, 6:13 am

China covid-19 protests weigh on us equities as sentiment sours amid growth worries

US equity benchmarks fell as an escalation of protests in China against stringent COVID-19 restrictions...

November 28, 2022, 7:14 pm

Risk aversion continues on china, euro support by yields

Risk aversion is the theme of the day as protests in China spread to multiple cities. There might be talks that pressure is mounting on the government...

November 28, 2022, 1:39 pm

Apple's china reliance grows perilous amid covid zero

Apple Inc. warned earlier this month that shipments of its newest iPhones will be lower than expected going into the peak holiday season, that was bef...

November 25, 2022, 12:04 pm

W. p. carey: despite inflation protection, stock is best suited for lower interest rates

Investors have flocked to WPC this year because of its peer-leading contractual inflation protections in the form of CPI-based rent esc...

November 21, 2022, 7:08 am

Monopar therapeutics (mnpr) up on soft tissue sarcoma study data

Monopar Therapeutics (MNPR) surges after it reports data from its ongoing phase Ib dose escalation stud...

November 18, 2022, 3:11 pm